BRAF and colorectal carcinoma: The advantage of this study is that on the basis of fully collecting the clinical and pathological information of patients including 24 variables in the training set, a clinical prognostic model in the form of a nomogram suitable for stage I-IV BRAF V600E-mutated CRC patients was established, and it has been verified in the verification set, which conforms to the TRIPOD specification.